SCHEDULE: Longitude Capital Reports Stake in Entera Bio

Longitude Capital Partners V, LLC and related entities report a 4.6% beneficial ownership stake in Entera Bio Ltd. ordinary shares.

Summary

• This filing is a Schedule 13G, indicating a change in beneficial ownership of Entera Bio Ltd. ordinary shares.
• Longitude Capital Partners V, LLC (LCPV), Longitude Venture Partners V, L.P. (LVPV), Patrick G. Enright, and Juliet Tammenoms Bakker are the reporting persons.
• LVPV is the record owner of 7,843,138 ordinary shares.
• LCPV, as the general partner of LVPV, and Messrs. Enright and Bakker, as managing members of LCPV, may be deemed to beneficially own these shares.
• The total beneficial ownership reported is 7,843,138 ordinary shares, representing 4.6% of the outstanding shares.
• The filing states that the reporting persons expressly disclaim beneficial ownership except to the extent of their pecuniary interest.
• The number of outstanding ordinary shares is stated as 172,251,411 as of July 28, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without new financial or strategic information.

Positives

• The reporting persons have acquired a significant stake (4.6%) in Entera Bio Ltd., which could indicate confidence in the company's future prospects.
• The filing is made in a timely manner, adhering to regulatory requirements.

Negatives

• The filing does not provide any new financial performance data or strategic updates for Entera Bio Ltd.
• The reporting persons disclaim beneficial ownership beyond their pecuniary interest, which may suggest a passive investment rather than active control.

Risks

• The filing does not explicitly mention any risks associated with Entera Bio Ltd. or the investment itself.
• Potential risks could include market volatility affecting the value of the ordinary shares held by the reporting persons.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Entera Bio Ltd.'s future performance or the reporting persons' investment strategy.

Management Comments

• Each Reporting Person disclaims beneficial ownership of all securities reported in this Statement except to the extent of such Reporting Person's pecuniary interest therein.
• The Reporting Persons expressly disclaim such group membership and beneficial ownership over any ordinary shares that they may be deemed to beneficially own by reason of such policies and procedures.
• This Schedule 13G shall not be deemed an admission that the Reporting Persons are members of a group for purposes of Section 13 of the Exchange Act or for any other purpose.

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically signal a passive investment stake, often by institutional investors, and do not usually reflect active management or control intentions. This filing places Entera Bio Ltd. within the context of institutional investment activity.

Stakeholder Impact

• Shareholders: May view the increased institutional interest positively, but the passive nature of the stake limits immediate impact on control.
• Management: Will be aware of the significant passive stake held by Longitude Capital, which could influence future strategic discussions.
• Creditors: No direct impact indicated by this filing.

Next Steps

• The reporting persons will continue to monitor their investment in Entera Bio Ltd.
• Future filings may be required if there are further changes in beneficial ownership.

Key Dates

Keywords

Entera Bio Ltd., Longitude Capital, Schedule 13G, Beneficial Ownership, Ordinary Shares, Investment Management, Delaware